Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

Tempus

Neither a doctor nor a teaching hospital

Research payments

$10,688,543

122 payments

Through program year 2024, Tempus is reported as receiving $10,688,543 in research payments, across 122 payments.

By program year

3 rows
Year Kind Amount Payments
2024 Research $1,420,319 7
2023 Research $6,967,642 71
2022 Research $2,300,582 44

Breakdown

Who paid Research payments · program years 2022–2024
  1. GlaxoSmithKline, LLC. $10,688,543 122 payments
Studies the money was for Research payments · program years 2022–2024
  1. 218046 $6,159,554 62 payments
  2. Study name not reported $3,108,670 53 payments
  3. 0000000000000000000000000000000000000000000000000000000000000000218046 $1,420,319 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record